ISL1 decreases cisplatin sensitivity of TNBC cells. (A) Compared with the vehicle group, treatment with 10 μM cisplatin induced a significant cell growth arrest, which was partially reversed by ISL1 overexpression and augmented by ISL1 silencing in MDA-MB-231 cells. (B) Compared with the vehicle group, treatment with 10 μM cisplatin induced a significant cell growth arrest, which was partially reversed by ISL1 overexpression and augmented by ISL1 silencing in MDA-MB-468 cells. (C) Compared with the vehicle group, significant cell apoptosis was induced by 10 μM cisplatin treatment, which was reversed by ISL1 overexpression and augmented by ISL1 silencing in MDA-MB-231 cells. (D) Compared with the vehicle group, significant cell apoptosis was induced by 10 μM cisplatin treatment, which was reversed by ISL1 overexpression and augmented by ISL1 silencing in MDA-MB-468 cells. *P<0.05, **P<0.01 and ***P<0.0001. siRNA, small interfering RNA; ISL1, Islet 1; OD, optical density; PI, propidium iodide.